A striking data point from Nature Reviews Disease Primers underscores the urgency of improving Buruli ulcer diagnostics across sub-Saharan Africa: diagnostic delays routinely exceed 12 months from symptom onset to confirmed diagnosis. This extended timeline dramatically worsens clinical outcomes, allowing the disease to progress from manageable early-stage lesions to severe, permanently disabling ulceration. Yet the evidence for rapid intervention is compelling—WHO-recommended oral antimicrobial regimens achieve cure rates exceeding 90% when initiated early in disease course. The disconnect between available solutions and their implementation reflects systemic gaps in laboratory infrastructure, trained personnel, and access to diagnostic tools in decentralized health facilities. Investment in molecular diagnostic capacity and supply chain strengthening for antimicrobial medications could fundamentally alter disease trajectories across affected regions, transforming both individual outcomes and population-level disease burden. Read the full article on GMJ Newsroom.
Was this article helpful?
